Biofil Chemicals Pharmaceuticals Stock Filter Stocks by Fundamentals
| BIOFILCHEM | 42.43 0.35 0.82% |
Biofil Chemicals Pharmaceuticals fundamentals help investors to digest information that contributes to Biofil Chemicals' financial success or failures. It also enables traders to predict the movement of Biofil Stock. The fundamental analysis module provides a way to measure Biofil Chemicals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biofil Chemicals stock.
| Last Reported | Projected for Next Year | ||
| Cash And Equivalents | 234 K | 222.3 K |
Biofil | Cash and Equivalents |
Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Biofil Fundamentals
| Return On Equity | 0.04 | ||||
| Return On Asset | 0.0144 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 704.4 M | ||||
| Shares Outstanding | 16.27 M | ||||
| Shares Owned By Insiders | 59.77 % | ||||
| Price To Book | 3.75 X | ||||
| Price To Sales | 1.73 X | ||||
| Revenue | 400.35 M | ||||
| Gross Profit | 25.29 M | ||||
| EBITDA | 13.06 M | ||||
| Net Income | 7.09 M | ||||
| Cash And Equivalents | 260 K | ||||
| Total Debt | 4.39 M | ||||
| Book Value Per Share | 11.40 X | ||||
| Cash Flow From Operations | 23.94 M | ||||
| Earnings Per Share | 0.38 X | ||||
| Number Of Employees | 26 | ||||
| Beta | 1.97 | ||||
| Market Capitalization | 702.05 M | ||||
| Total Asset | 470.83 M | ||||
| Retained Earnings | (316.94 M) | ||||
| Working Capital | 98.83 M | ||||
| Net Asset | 470.83 M |
About Biofil Chemicals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biofil Chemicals Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biofil Chemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biofil Chemicals Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Biofil Stock
Biofil Chemicals financial ratios help investors to determine whether Biofil Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biofil with respect to the benefits of owning Biofil Chemicals security.